DossierENTITY

drug pricing reform

Coverage of drug pricing reform in the Nexus archive.

Co-mentioned in this coverage

Recent coverage

HEALTHNIKKEI ASIA
Japan risks losing out without drug pricing reform, warns AstraZeneca CEO
AstraZeneca's CEO warns that Japan risks falling behind without drug pricing reform. The warning highlights potential consequences for Japan's pharmaceutical market and competitiveness.

drug pricing reform · Dossier · The Nexus